TSND logo

TerrAscend Corp. Stock Price

TSX:TSND Community·CA$279.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

TSND Share Price Performance

CA$0.74
0.13 (21.31%)
CA$2.01
Fair Value
CA$0.74
0.13 (21.31%)
63.1% undervalued intrinsic discount
CA$2.01
Fair Value
Price CA$0.74
AnalystHighTarget CA$2.01
AnalystLowTarget CA$1.50
AnalystConsensusTarget CA$1.86

TSND Community Narratives

·
Fair Value CA$2.01 63.1% undervalued intrinsic discount

US Cannabis Legalization And Digital Health Will Unlock Opportunities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$1.5 50.8% undervalued intrinsic discount

North American Cannabis Will Face Oversupply And Risks Yet Recover

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$1.88 60.6% undervalued intrinsic discount

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
CA$1.5
50.8% undervalued intrinsic discount
Profit Margin
7.83%
Future PE
17.6x
Price in 2029
CA$1.82
CA$2.01
63.1% undervalued intrinsic discount
Profit Margin
7.83%
Future PE
23.67x
Price in 2029
CA$2.41

Trending Discussion

No trending discussion available.

Updated Narratives

TSND logo

TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside

Fair Value: CA$1.5 50.8% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TSND logo

TSND: Expanding M&A Pipeline And New Leadership Will Support Future Profitability

Fair Value: CA$2.01 63.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TSND logo

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

Fair Value: CA$1.88 60.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with mediocre balance sheet.

1 Risk
2 Rewards

TerrAscend Corp. Key Details

US$261.8m

Revenue

US$125.5m

Cost of Revenue

US$136.2m

Gross Profit

US$164.5m

Other Expenses

-US$28.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
-0.091
52.04%
-10.81%
245.4%
View Full Analysis

About TSND

Founded
2017
Employees
933
CEO
Ziad Ghanem
WebsiteView website
www.terrascend.com

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Recent TSND News & Updates

Narrative Update Jul 02

TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside

Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.

Recent updates

No updates